Development of a thermotherapy device for the treatment of cutaneous leishmaniasis

The founders of DermatoTherma have developed a cost-effective thermotherapy device in the form of a demonstrator that can be used to treat cutaneous leishmaniasis disease and is being prepared for FDA approval.

Development of an end-of-line test system

konplan supported PharmaSens in the development of a new type of insulin patch pump "niia essential".